Baker Bros. Advisors LP Instil Bio, Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.63 $227,757 - $358,718	-569,394 Reduced 10.8%	4,704,395 $2.02 Million
Q4 2022 Feb 14, 2023	BUY	$0.48 - $5.33 $662,442 - $7.36 Million	1,380,089 Added 35.44%	5,273,789 $3.32 Million
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $94.3 Million - $105 Million	3,893,700 New	3,893,700 $97.7 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $8.8B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.